Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR007077)
Formula Reactant Dapoxetine Product Dapoxetine Metabolite M3
Reactant Info Product Info
Metabolic Type Oxidation - Hydrolyzationn
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR007073 Dapoxetine Dapoxetine Metabolite M1 Oxidation - N-dealkylation Dapoxetine [1]
MR007079 Dapoxetine Dapoxetine Metabolite M11 Other reaction - Deacylation Dapoxetine [1]
MR007083 Dapoxetine Dapoxetine Metabolite M7 Oxidation - Hydrolyzationn Dapoxetine [1]
MR007081 Dapoxetine Dapoxetine-n-oxide Oxidation - Oxidationn Dapoxetine [1]
MR007085 Dapoxetine Didesmethyldapoxetine Unclear Dapoxetine [2]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR007078 Dapoxetine Metabolite M3 Dapoxetine Metabolite M2 Oxidation - Demethylation Dapoxetine [1]
References
1 Characterization of Phase I Hepatic Metabolites of Anti-Premature Ejaculation Drug Dapoxetine by UHPLC-ESI-Q-TOF
2 Dapoxetine: a new option in the medical management of premature ejaculation. Ther Adv Urol. 2012 Oct;4(5):233-51.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.